Description
Skin Types: All skin types, especially dry, dull, or uneven
Concerns: Dullness, uneven skin tone, dehydration, loss of elasticity
Why We Love It
The K-SECRET SEOUL 1988 Capsule Cream is a K-beauty innovation featuring a unique dual texture—a lightweight gel base infused with Vitamin C capsules that burst on application, delivering an instant boost of brightness and nourishment.
With 5% Niacinamide and Yuja (Citrus Junos) Oil, it helps fade dullness, refine uneven tone, and restore radiance. Meanwhile, Hippophae Rhamnoides Water (sea buckthorn), Collagen Water, and multiple forms of Hyaluronic Acid deliver deep hydration and improve skin elasticity, while Squalane locks in moisture and strengthens the skin barrier.
The result? Skin that feels plump, smooth, hydrated, and luminous with every application.
Key Benefits:
Deep Hydration & Nourishment: Hyaluronic acids, collagen, and squalane replenish and protect moisture levels.
Brightening & Even Tone: 5% Niacinamide + Yuja Oil visibly brighten dull skin and refine uneven complexion.
Vitamin C Boost: Encapsulated capsules deliver antioxidants for radiant, youthful skin.
Dual-Texture Cream: Gel + capsules create a refreshing, lightweight finish without stickiness.
All-in-One Formula: Works as moisturizer + brightener + nourishing treatment.
Hero Ingredients:
Niacinamide 5% – Improves skin tone, refines pores, and brightens
Yuja Oil – Rich in Vitamin C, revitalizes dull skin
Hippophae Rhamnoides Water (Sea Buckthorn) – Nourishes and strengthens skin
Collagen Water – Improves firmness and elasticity
Squalane – Deep hydration and barrier support
Multi Hyaluronic Acids – Intense moisture for plump, supple skin
How to Use:
Use as the final step in your skincare routine.
Apply an even layer to face and neck.
Gently pat for full absorption.
Use daily, morning and night, for best results.
The K-SECRET SEOUL 1988 Capsule Cream : Niacinamide 5% + Yuja 50ml is your go-to moisturizer for hydrated, bright, and even-toned skin—all in one step.




Reviews
There are no reviews yet.